Agrawal PB, Wang R, Li HL, Schmitz-Abe K, Simone-Roach C, Chen J, Shi J, Louie T, Sheng S, Towne MC, Brainson CF, Matthay MA, Kim CF, Bamshad M, Emond MJ, Gerard NP, Kleyman TR, Gerard C.

P30 DK079307 NIDDK NIH HHS , U01 HL100402 NHLBI NIH HHS , U19 HD077671 NICHD NIH HHS , R01 AR068429 NIAMS NIH HHS , R37 HL051856 NHLBI NIH HHS , R01 HL090136 NHLBI NIH HHS , U54 HD090255 NICHD NIH HHS , R01 HL125821 NHLBI NIH HHS , R01 HL132266 NHLBI NIH HHS

Abou Alaiwa, Neonates with cystic fibrosis have a reduced nasal liquid pH; a small pilot study. 2014, Pubmed

Abou Alaiwa, Neonates with cystic fibrosis have a reduced nasal liquid pH; a small pilot study. 2014, Pubmed
Babini, A new subunit of the epithelial Na+ channel identifies regions involved in Na+ self-inhibition. 2003, Pubmed , Xenbase
Bangel-Ruland, Characterization of the epithelial sodium channel delta-subunit in human nasal epithelium. 2010, Pubmed
Blohmke, TLR5 as an anti-inflammatory target and modifier gene in cystic fibrosis. 2010, Pubmed
Boucher, Pathogenesis of cystic fibrosis airways disease. 2001, Pubmed
Boucher, Airway surface dehydration in cystic fibrosis: pathogenesis and therapy. 2007, Pubmed
Canessa, Amiloride-sensitive epithelial Na+ channel is made of three homologous subunits. 1994, Pubmed , Xenbase
Chen, Mutations in the extracellular loop of alpha-rENaC alter sensitivity to amiloride and reactive species. 2004, Pubmed , Xenbase
Chen, Loss of anion transport without increased sodium absorption characterizes newborn porcine cystic fibrosis airway epithelia. 2010, Pubmed
Chen, Gain-of-function variant of the human epithelial sodium channel. 2013, Pubmed , Xenbase
Chen, Probing the structural basis of Zn2+ regulation of the epithelial Na+ channel. 2012, Pubmed , Xenbase
Cutting, Modifier genes in Mendelian disorders: the example of cystic fibrosis. 2010, Pubmed
Donaldson, New pulmonary therapies directed at targets other than CFTR. 2013, Pubmed
Drumm, Genetic modifiers of lung disease in cystic fibrosis. 2005, Pubmed
Drumm, Genetic variation and clinical heterogeneity in cystic fibrosis. 2012, Pubmed
Emond, Exome Sequencing of Phenotypic Extremes Identifies CAV2 and TMC6 as Interacting Modifiers of Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis. 2015, Pubmed
Garty, Epithelial sodium channels: function, structure, and regulation. 1997, Pubmed
Goldin, Expression of ion channels by injection of mRNA into Xenopus oocytes. 1991, Pubmed , Xenbase
Gorlov, Evolutionary evidence of the effect of rare variants on disease etiology. 2011, Pubmed
Hirsh, Evaluation of second generation amiloride analogs as therapy for cystic fibrosis lung disease. 2004, Pubmed
Hobbs, Does epithelial sodium channel hyperactivity contribute to cystic fibrosis lung disease? 2013, Pubmed
Hughey, Epithelial sodium channels are activated by furin-dependent proteolysis. 2004, Pubmed , Xenbase
Iles, What can genome-wide association studies tell us about the genetics of common disease? 2008, Pubmed
Ji, δ ENaC: a novel divergent amiloride-inhibitable sodium channel. 2012, Pubmed
Ji, Delta-subunit confers novel biophysical features to alpha beta gamma-human epithelial sodium channel (ENaC) via a physical interaction. 2006, Pubmed
Joo, Marked increases in mucociliary clearance produced by synergistic secretory agonists or inhibition of the epithelial sodium channel. 2016, Pubmed
Joo, Hyposecretion, not hyperabsorption, is the basic defect of cystic fibrosis airway glands. 2006, Pubmed
Joshi, Mutations in the substrate binding glycine-rich loop of the mitochondrial processing peptidase-α protein (PMPCA) cause a severe mitochondrial disease. 2016, Pubmed
Kashlan, Constraint-based, homology model of the extracellular domain of the epithelial Na+ channel α subunit reveals a mechanism of channel activation by proteases. 2011, Pubmed
Kashlan, ENaC structure and function in the wake of a resolved structure of a family member. 2011, Pubmed
Kellenberger, An external site controls closing of the epithelial Na+ channel ENaC. 2002, Pubmed , Xenbase
Knowles, A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis. 1990, Pubmed
Knowles, The influence of genetics on cystic fibrosis phenotypes. 2012, Pubmed
Knowles, Aerosolized amiloride as treatment of cystic fibrosis lung disease: a pilot study. 1991, Pubmed
Lee, Optimal unified approach for rare-variant association testing with application to small-sample case-control whole-exome sequencing studies. 2012, Pubmed
LeGrys, Diagnostic sweat testing: the Cystic Fibrosis Foundation guidelines. 2007, Pubmed
Liou, Year-to-year changes in lung function in individuals with cystic fibrosis. 2010, Pubmed
Lu, Small molecule activator of the human epithelial sodium channel. 2008, Pubmed , Xenbase
Mall, Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice. 2004, Pubmed
McIntosh, Cystic fibrosis transmembrane conductance regulator and the etiology and pathogenesis of cystic fibrosis. 1992, Pubmed
Myerburg, Airway surface liquid volume regulates ENaC by altering the serine protease-protease inhibitor balance: a mechanism for sodium hyperabsorption in cystic fibrosis. 2006, Pubmed
Nejentsev, Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. 2009, Pubmed
Pezzulo, Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung. 2012, Pubmed
Quinton, Cystic fibrosis: lessons from the sweat gland. 2007, Pubmed
Rauh, δβγ-ENaC is inhibited by CFTR but stimulated by cAMP in Xenopus laevis oocytes. 2017, Pubmed , Xenbase
Rauh, A mutation in the β-subunit of ENaC identified in a patient with cystic fibrosis-like symptoms has a gain-of-function effect. 2013, Pubmed , Xenbase
Schoenberger, Novel small molecule epithelial sodium channel inhibitors as potential therapeutics in cystic fibrosis - a patent evaluation. 2013, Pubmed
Sheng, Extracellular histidine residues crucial for Na+ self-inhibition of epithelial Na+ channels. 2004, Pubmed , Xenbase
Sheng, External nickel inhibits epithelial sodium channel by binding to histidine residues within the extracellular domains of alpha and gamma subunits and reducing channel open probability. 2002, Pubmed , Xenbase
Shi, Extracellular finger domain modulates the response of the epithelial sodium channel to shear stress. 2012, Pubmed , Xenbase
Singh, Synergistic and additive killing by antimicrobial factors found in human airway surface liquid. 2000, Pubmed
Stanke, The TNFalpha receptor TNFRSF1A and genes encoding the amiloride-sensitive sodium channel ENaC as modulators in cystic fibrosis. 2006, Pubmed
Stoltz, Origins of cystic fibrosis lung disease. 2015, Pubmed
Stutts, CFTR as a cAMP-dependent regulator of sodium channels. 1995, Pubmed
Su, A gene atlas of the mouse and human protein-encoding transcriptomes. 2004, Pubmed
Tan, Cathepsin B contributes to Na+ hyperabsorption in cystic fibrosis airway epithelial cultures. 2014, Pubmed , Xenbase
Waldmann, Functional degenerin-containing chimeras identify residues essential for amiloride-sensitive Na+ channel function. 1995, Pubmed
Waldmann, Molecular cloning and functional expression of a novel amiloride-sensitive Na+ channel. 1995, Pubmed , Xenbase
Winarski, Extracellular allosteric regulatory subdomain within the gamma subunit of the epithelial Na+ channel. 2010, Pubmed , Xenbase
Wright, Genome-wide association and linkage identify modifier loci of lung disease severity in cystic fibrosis at 11p13 and 20q13.2. 2011, Pubmed
Yamamura, Epithelial Na+ channel delta subunit is an acid sensor in the human oesophagus. 2008, Pubmed , Xenbase
Yamamura, Protons activate the delta-subunit of the epithelial Na+ channel in humans. 2004, Pubmed , Xenbase
Yang, Highly conserved salt bridge stabilizes rigid signal patch at extracellular loop critical for surface expression of acid-sensing ion channels. 2012, Pubmed
Zhao, Characterization of a novel splice variant of δ ENaC subunit in human lungs. 2012, Pubmed , Xenbase
Zielenski, Cystic fibrosis: genotypic and phenotypic variations. 1995, Pubmed